AU717906B2 - Supplemented and unsupplemented tissue sealants, methods of their production and use - Google Patents
Supplemented and unsupplemented tissue sealants, methods of their production and use Download PDFInfo
- Publication number
- AU717906B2 AU717906B2 AU45100/96A AU4510096A AU717906B2 AU 717906 B2 AU717906 B2 AU 717906B2 AU 45100/96 A AU45100/96 A AU 45100/96A AU 4510096 A AU4510096 A AU 4510096A AU 717906 B2 AU717906 B2 AU 717906B2
- Authority
- AU
- Australia
- Prior art keywords
- fibrin
- wound
- growth factor
- fibrin sealant
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35100694A | 1994-12-07 | 1994-12-07 | |
US08/351006 | 1994-12-07 | ||
PCT/US1995/015876 WO1996017633A1 (en) | 1994-12-07 | 1995-12-06 | Supplemented and unsupplemented tissue sealants, methods of their production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4510096A AU4510096A (en) | 1996-06-26 |
AU717906B2 true AU717906B2 (en) | 2000-04-06 |
Family
ID=23379191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45100/96A Withdrawn - After Issue AU717906B2 (en) | 1994-12-07 | 1995-12-06 | Supplemented and unsupplemented tissue sealants, methods of their production and use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0796115A1 (ja) |
JP (1) | JP4223548B2 (ja) |
AU (1) | AU717906B2 (ja) |
CA (1) | CA2207289C (ja) |
WO (1) | WO1996017633A1 (ja) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US6197325B1 (en) | 1990-11-27 | 2001-03-06 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US7196054B1 (en) | 1990-11-27 | 2007-03-27 | The American National Red Cross | Methods for treating wound tissue and forming a supplemented fibrin matrix |
US6117425A (en) | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
JPH11507277A (ja) * | 1995-06-07 | 1999-06-29 | ジ・アメリカン・ナショナル・レッド・クロス | 補足された及び補足されていない組織シーラント、その製造法及び使用法 |
EP0993311B1 (en) | 1997-06-18 | 2012-11-14 | Angiotech Pharmaceuticals (US), Inc. | Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof |
AT407117B (de) * | 1997-09-19 | 2000-12-27 | Immuno Ag | Fibrinschwamm |
WO1999025782A2 (en) * | 1997-11-17 | 1999-05-27 | Haemacure Corporation | Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
US6056970A (en) * | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
US7601685B2 (en) | 1998-08-27 | 2009-10-13 | Eidgenossische Technische Hochschule Zurich | Growth factor modified protein matrices for tissue engineering |
US7241730B2 (en) | 1998-08-27 | 2007-07-10 | Universitat Zurich | Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides |
JP2003026673A (ja) * | 1999-03-05 | 2003-01-29 | Asahi Kasei Corp | 骨形成促進剤 |
JP3576063B2 (ja) | 2000-02-22 | 2004-10-13 | 株式会社ホギメディカル | 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法 |
US6921532B1 (en) | 2000-06-22 | 2005-07-26 | Spinal Restoration, Inc. | Biological Bioadhesive composition and methods of preparation and use |
WO2001097872A1 (en) * | 2000-06-22 | 2001-12-27 | Austin Sam L | Bioadhesive compositions and methods of preparation and use |
US7247609B2 (en) | 2001-12-18 | 2007-07-24 | Universitat Zurich | Growth factor modified protein matrices for tissue engineering |
US8124075B2 (en) | 2004-07-16 | 2012-02-28 | Spinal Restoration, Inc. | Enhanced biological autologous tissue adhesive composition and methods of preparation and use |
US8206448B2 (en) | 2004-10-29 | 2012-06-26 | Spinal Restoration, Inc. | Injection of fibrin sealant using reconstituted components in spinal applications |
US8419722B2 (en) | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
US7597687B2 (en) | 2004-10-29 | 2009-10-06 | Spinal Restoration, Inc. | Injection of fibrin sealant including an anesthetic in spinal applications |
US8403923B2 (en) | 2004-10-29 | 2013-03-26 | Spinal Restoration, Inc. | Injection of fibrin sealant in the absence of corticosteroids in spinal applications |
US9358318B2 (en) | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
DK1809342T3 (en) * | 2004-10-20 | 2015-08-17 | Ethicon Inc | absorbable hemostat |
US8575101B2 (en) | 2005-01-06 | 2013-11-05 | Kuros Biosurgery Ag | Supplemented matrices for the repair of bone fractures |
WO2006073711A2 (en) | 2005-01-06 | 2006-07-13 | Kuros Biosurgery Ag | Use of a matrix comprising a contrast agent in soft tissues |
KR101617319B1 (ko) | 2005-04-12 | 2016-05-02 | 메소블라스트, 아이엔씨. | 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리 |
US7429241B2 (en) | 2005-09-29 | 2008-09-30 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
KR100701552B1 (ko) * | 2006-06-23 | 2007-03-30 | 한국과학기술연구원 | 압축기체를 이용한 필라멘트 및 시트 형태의 생분해성폴리에스테르 고분자 소재의 제조방법 |
GB0623607D0 (en) * | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
EP2111239B1 (en) | 2006-12-15 | 2013-03-06 | Lifebond Ltd. | Gelatin-transglutaminase hemostatic dressings and sealants |
ATE543520T1 (de) | 2007-04-13 | 2012-02-15 | Kuros Biosurgery Ag | Polymergewebeversiegelung |
WO2009018613A1 (en) | 2007-08-06 | 2009-02-12 | Angioblast Systems, Inc. | Methods of generating, repairing and/or maintaining connective tissue in vivo |
CA2710798A1 (en) | 2007-12-28 | 2009-07-09 | Kuros Biosurgery Ag | Pdgf fusion proteins incorporated into fibrin foams |
EP2487206A3 (en) | 2008-06-18 | 2012-11-28 | Lifebond Ltd | Cross-linkable gelatin-based compositions |
CN106995797B (zh) | 2008-08-18 | 2021-04-30 | 中胚有限公司 | 单克隆抗体stro-4 |
US9827205B2 (en) | 2008-12-12 | 2017-11-28 | Mallinckrodt Pharma Ip Trading D.A.C. | Dry powder fibrin sealant |
ES2551388T3 (es) | 2009-12-22 | 2015-11-18 | Lifebond Ltd | Modificación de agentes de entrecruzamiento enzimáticos para controlar las propiedades de las matrices entrecruzadas |
WO2011083154A1 (en) | 2010-01-08 | 2011-07-14 | Profibrix Bv | Dry powder fibrin sealant |
AU2011287215B2 (en) | 2010-08-05 | 2015-09-10 | Lifebond Ltd. | Dry composition wound dressings and adhesives |
EP2686027B1 (en) | 2011-03-16 | 2021-05-05 | Kuros Biosurgery AG | Pharmaceutical formulation for use in spinal fusion |
US8999376B2 (en) * | 2012-02-03 | 2015-04-07 | Xcede Technologies, Inc. | Tissue patch |
GB201400292D0 (en) | 2014-01-08 | 2014-02-26 | Haemostatix Ltd | Peptide dendrimers and agents |
US10751444B2 (en) | 2015-08-07 | 2020-08-25 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
US10588998B2 (en) | 2015-08-07 | 2020-03-17 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
US9833538B2 (en) | 2015-08-07 | 2017-12-05 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
US10660945B2 (en) | 2015-08-07 | 2020-05-26 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
KR101878769B1 (ko) | 2017-04-03 | 2018-08-16 | 조석형 | 저분자 cm-1,3-베타글루칸 칼슘염 분말 지혈제 |
DE102017126149A1 (de) * | 2017-11-08 | 2019-05-09 | Johannes Gutenberg-Universität Mainz | Wirkstoffhaltiger Schichtverbund sowie Verfahren zu dessen Herstellung |
JP2022502482A (ja) * | 2018-09-17 | 2022-01-11 | ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム | 骨損傷を治療するための組成物及び方法 |
WO2021078986A1 (en) * | 2019-10-23 | 2021-04-29 | Fibriant B.V. | Fibrinogen as adjuvant for antimicrobial agents and therapy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009301A1 (en) * | 1990-11-27 | 1992-06-11 | The American National Red Cross | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
EP0562864A1 (en) * | 1992-03-25 | 1993-09-29 | JOHNSON & JOHNSON MEDICAL, INC. | Heteromorphic sponges containing active agents |
WO1994020133A1 (en) * | 1993-03-12 | 1994-09-15 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4706662A (en) * | 1981-12-11 | 1987-11-17 | Johnson & Johnson Products, Inc. | Film dressing with fabric backing |
FR2589737A1 (fr) * | 1985-11-12 | 1987-05-15 | Dow Corning Sa | Procedes de fabrication de pansements |
US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
-
1995
- 1995-12-06 WO PCT/US1995/015876 patent/WO1996017633A1/en active Application Filing
- 1995-12-06 AU AU45100/96A patent/AU717906B2/en not_active Withdrawn - After Issue
- 1995-12-06 JP JP51775396A patent/JP4223548B2/ja not_active Expired - Lifetime
- 1995-12-06 EP EP95943692A patent/EP0796115A1/en not_active Ceased
- 1995-12-06 CA CA002207289A patent/CA2207289C/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009301A1 (en) * | 1990-11-27 | 1992-06-11 | The American National Red Cross | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
EP0562864A1 (en) * | 1992-03-25 | 1993-09-29 | JOHNSON & JOHNSON MEDICAL, INC. | Heteromorphic sponges containing active agents |
WO1994020133A1 (en) * | 1993-03-12 | 1994-09-15 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
Also Published As
Publication number | Publication date |
---|---|
JPH10510183A (ja) | 1998-10-06 |
AU4510096A (en) | 1996-06-26 |
WO1996017633A1 (en) | 1996-06-13 |
CA2207289A1 (en) | 1996-06-13 |
JP4223548B2 (ja) | 2009-02-12 |
CA2207289C (en) | 2005-04-12 |
EP0796115A1 (en) | 1997-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU717906B2 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US6117425A (en) | Supplemented and unsupplemented tissue sealants, method of their production and use | |
US6559119B1 (en) | Method of preparing a tissue sealant-treated biomedical material | |
US6197325B1 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US6054122A (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US7196054B1 (en) | Methods for treating wound tissue and forming a supplemented fibrin matrix | |
AU696691B2 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
WO1996017633A9 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
WO1996040174A1 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US6124273A (en) | Chitin hydrogels, methods of their production and use | |
Krishnan et al. | Comparative evaluation of absorbable hemostats: advantages of fibrin-based sheets | |
AU3788299A (en) | Compositions comprising hemostatic compounds and bioabsorbable polymers | |
KR20010090876A (ko) | 콜라겐 지혈 섬유 | |
AU733471B2 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
AU778583B2 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
AU5053200A (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20020313 |
|
CFC | Opposition proceedings - application withdrawn |
Opponent name: BAXTER HEALTHCARE CORPORATION |
|
MK12 | Application lapsed section 141(1)/reg 8.3(2) - applicant filed a written notice of withdrawal |